Biotech

All Articles

Cassava spends $40M over allegedly deceptive Alzheimer's improve

.Cassava Sciences has accepted to pay $40 thousand to deal with an inspection in to cases it made mi...

Merck bags choices on Evaxion's AI-designed vaccination prospects

.Merck &amp Co. has gotten possibilities on 2 Evaxion Biotech injection prospects, paying for $3.2 m...

Enanta's RSV antiviral crushes virus-like lots in difficulty research study

.Enanta Pharmaceuticals has actually linked its own breathing syncytial virus (RSV) antiviral to sig...

Biogen cans SAGE-324 cooperation after vital shake fall short

.Biogen has conducted the final rites to its collaboration along with Sage Therapeutics on SAGE-324,...

AbbVie Parkinson's drug coming from $8.7 B Cerevel buyout scores

.On the very same day that some Parkinson's ailment drugs are being actually called into question, A...

Arch shuts $3B-plus fund to foster biopharma startups

.On the heels of a $3 billion fund from Bain Capital Life Sciences, Arch Endeavor Partners is showin...

Orion to utilize Aitia's 'electronic twins' to locate brand-new cancer cells medicines

.Finnish biotech Orion has actually snooped potential in Aitia's "digital double" tech to create new...

Windtree's surprise med rears blood pressure in most recent stage 2 succeed

.While Windtree Rehabs has battled to develop the monetary roots required to make it through, a phas...

2 cancer cells biotechs merge, developing worldwide footprint

.OncoC4 is taking AcroImmune-- as well as its own in-house professional production abilities-- under...

Amgen reports first phase 3 win for $400M eczema drug

.Amgen has actually shared (PDF) the first period 3 information on its own $400 thousand eczema drug...